Position in ROIV
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$6,675
+$1,446 QoQ
Shares Held
241
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Red Tortoise LLC holds $78,810 across 13 Biotechnology names. ROIV ranks #6 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
317 | $15,206 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
256 | $12,584 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
35 | $6,987 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9 | $6,953 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
698 | $6,945 | |
| 6 | ROIV |
Roivant Sciences Ltd.
This page
|
241 | $6,675 | |
| 7 | IMVT |
Immunovant, Inc.
|
242 | $6,011 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
69 | $5,807 |
All Filings in ROIV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,675 | 241 | Shares | Other | 2026-04-21 | |
| 2025-12-31 | $5,229 | 241 | Shares | Other | 2026-01-22 | |
| 2025-09-30 | $3,646 | 241 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $2,716 | 241 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $2,431 | 241 | Shares | Other | 2025-04-25 | |
| 2024-12-31 | $2,851 | 241 | Shares | Other | 2025-01-24 | |
| 2024-09-30 | $2,781 | 241 | Shares | Other | 2024-10-28 | |
| 2024-06-30 | $2,547 | 241 | Shares | Other | 2024-07-31 | |
| 2024-03-31 | $2,540 | 241 | Shares | Other | 2024-04-19 | |
| 2023-12-31 | $2,706 | 241 | Shares | Other | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||